MedPath

Catalent Belgium SA

🇧🇪Belgium
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

SFDA:2

Drug Approvals

HADLIMA 40MG/0.8ML INJECTION IN PFP

Approval Date
Jul 18, 2025
SFDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.